Cargando…

Investigation of Ultrasound-Mediated Intracellular Ca(2+) Oscillations in HIT-T15 Pancreatic β-Cell Line

In glucose-stimulated insulin secretion (GSIS) of pancreatic β-cells, the rise of free cytosolic Ca(2+) concentration through voltage-gated calcium channels (VGCCs) triggers the exocytosis of insulin-containing granules. Recently, mechanically induced insulin secretion pathways were also reported, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Chi Woo, Lee, Nan Sook, Koo, Kweon Mo, Moon, Sunho, Goo, Kyosuk, Jung, Hayong, Yoon, Changhan, Lim, Hae Gyun, Shung, K. Kirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290496/
https://www.ncbi.nlm.nih.gov/pubmed/32375298
http://dx.doi.org/10.3390/cells9051129
Descripción
Sumario:In glucose-stimulated insulin secretion (GSIS) of pancreatic β-cells, the rise of free cytosolic Ca(2+) concentration through voltage-gated calcium channels (VGCCs) triggers the exocytosis of insulin-containing granules. Recently, mechanically induced insulin secretion pathways were also reported, which utilize free cytosolic Ca(2+) ions as a direct regulator of exocytosis. In this study, we aimed to investigate intracellular Ca(2+) responses on the HIT-T15 pancreatic β-cell line upon low-intensity pulsed ultrasound (LIPUS) stimulation and found that ultrasound induces two distinct types of intracellular Ca(2+) oscillation, fast-irregular and slow-periodic, from otherwise resting cells. Both Ca(2+) patterns depend on the purinergic signaling activated by the rise of extracellular ATP or ADP concentration upon ultrasound stimulation, which facilitates the release through mechanosensitive hemichannels on the plasma membrane. Further study demonstrated that two subtypes of purinergic receptors, P(2)X and P(2)Y, are working in a competitive manner depending on the level of glucose in the cell media. The findings can serve as an essential groundwork providing an underlying mechanism for the development of a new therapeutic approach for diabetic conditions with further validation.